BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 35725453)

  • 1. Myeloid DNA methyltransferase3b deficiency aggravates pulmonary fibrosis by enhancing profibrotic macrophage activation.
    Qin W; Spek CA; Scicluna BP; van der Poll T; Duitman J
    Respir Res; 2022 Jun; 23(1):162. PubMed ID: 35725453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL20Rb aggravates pulmonary fibrosis through enhancing bone marrow derived profibrotic macrophage activation.
    Zhu J; Jiang Q; Gao S; Xia Q; Zhang H; Liu B; Zhao R; Jiang H; Li X; Xu A; Zhou H; Xu Z; Yang C
    Pharmacol Res; 2024 May; 203():107178. PubMed ID: 38583686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of TIM-3 in Macrophages Aggravates Pathogenesis of Pulmonary Fibrosis in Mice.
    Wang Y; Kuai Q; Gao F; Wang Y; He M; Zhou H; Han G; Jiang X; Ren S; Yu Q
    Am J Respir Cell Mol Biol; 2019 Dec; 61(6):727-736. PubMed ID: 31162951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rac2 is required for alternative macrophage activation and bleomycin induced pulmonary fibrosis; a macrophage autonomous phenotype.
    Joshi S; Singh AR; Wong SS; Zulcic M; Jiang M; Pardo A; Selman M; Hagood JS; Durden DL
    PLoS One; 2017; 12(8):e0182851. PubMed ID: 28817691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotinamide phosphoribosyltransferase prompts bleomycin-induced pulmonary fibrosis by driving macrophage M2 polarization in mice.
    Chen Y; Wang T; Liang F; Han J; Lou Z; Yu Y; Li J; Zhan T; Gu Y; Dong L; Jiang B; Zhang W; Wu M; Lu Y
    Theranostics; 2024; 14(7):2794-2815. PubMed ID: 38773984
    [No Abstract]   [Full Text] [Related]  

  • 6. IRAK-M promotes alternative macrophage activation and fibroproliferation in bleomycin-induced lung injury.
    Ballinger MN; Newstead MW; Zeng X; Bhan U; Mo XM; Kunkel SL; Moore BB; Flavell R; Christman JW; Standiford TJ
    J Immunol; 2015 Feb; 194(4):1894-904. PubMed ID: 25595781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alveolar epithelial TET2 is not involved in the development of bleomycin-induced pulmonary fibrosis.
    Qin W; Crestani B; Spek CA; Scicluna BP; van der Poll T; Duitman J
    FASEB J; 2021 May; 35(5):e21599. PubMed ID: 33913570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor-α accelerates the resolution of established pulmonary fibrosis in mice by targeting profibrotic lung macrophages.
    Redente EF; Keith RC; Janssen W; Henson PM; Ortiz LA; Downey GP; Bratton DL; Riches DW
    Am J Respir Cell Mol Biol; 2014 Apr; 50(4):825-37. PubMed ID: 24325577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LRRK2 plays essential roles in maintaining lung homeostasis and preventing the development of pulmonary fibrosis.
    Tian Y; Lv J; Su Z; Wu T; Li X; Hu X; Zhang J; Wu L
    Proc Natl Acad Sci U S A; 2021 Aug; 118(35):. PubMed ID: 34446559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid-specific deletion of activating transcription factor 6 alpha increases CD11b
    Mekhael O; Revill SD; Hayat AI; Cass SP; MacDonald K; Vierhout M; Ayoub A; Reihani A; Padwal M; Imani J; Ayaub E; Yousof T; Dvorkin-Gheva A; Rullo A; Hirota JA; Richards CD; Bridgewater D; Stämpfli MR; Hambly N; Naqvi A; Kolb MR; Ask K
    Immunol Cell Biol; 2023 May; 101(5):412-427. PubMed ID: 36862017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TREM2 Insufficiency Protects against Pulmonary Fibrosis by Inhibiting M2 Macrophage Polarization.
    Luo Q; Deng D; Li Y; Shi H; Zhao J; Qian Q; Wang W; Cai J; Yu W; Liu J
    Int Immunopharmacol; 2023 May; 118():110070. PubMed ID: 37003186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppressing Sart1 to modulate macrophage polarization by siRNA-loaded liposomes: a promising therapeutic strategy for pulmonary fibrosis.
    Pan T; Zhou Q; Miao K; Zhang L; Wu G; Yu J; Xu Y; Xiong W; Li Y; Wang Y
    Theranostics; 2021; 11(3):1192-1206. PubMed ID: 33391530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained PI3K Activation exacerbates BLM-induced Lung Fibrosis via activation of pro-inflammatory and pro-fibrotic pathways.
    Kral JB; Kuttke M; Schrottmaier WC; Birnecker B; Warszawska J; Wernig C; Paar H; Salzmann M; Sahin E; Brunner JS; Österreicher C; Knapp S; Assinger A; Schabbauer G
    Sci Rep; 2016 Mar; 6():23034. PubMed ID: 26971883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surfactant protein-D regulates effector cell function and fibrotic lung remodeling in response to bleomycin injury.
    Aono Y; Ledford JG; Mukherjee S; Ogawa H; Nishioka Y; Sone S; Beers MF; Noble PW; Wright JR
    Am J Respir Crit Care Med; 2012 Mar; 185(5):525-36. PubMed ID: 22198976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of DNA methylation de-represses peroxisome proliferator-activated receptor-γ and attenuates pulmonary fibrosis.
    Wei A; Gao Q; Chen F; Zhu X; Chen X; Zhang L; Su X; Dai J; Shi Y; Cao W
    Br J Pharmacol; 2022 Apr; 179(7):1304-1318. PubMed ID: 34378791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased levels of Gab1 and Gab2 adaptor proteins skew interleukin-4 (IL-4) signaling toward M2 macrophage-driven pulmonary fibrosis in mice.
    Guo X; Li T; Xu Y; Xu X; Zhu Z; Zhang Y; Xu J; Xu K; Cheng H; Zhang X; Ke Y
    J Biol Chem; 2017 Aug; 292(34):14003-14015. PubMed ID: 28687632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic deficiency of the transcription factor NFAT1 confers protection against fibrogenic responses independent of immune influx.
    Vittal R; Walker NM; McLinden AP; Braeuer RR; Ke F; Fattahi F; Combs MP; Misumi K; Aoki Y; Wheeler DS; Wilke CA; Huang SK; Moore BB; Cao P; Lama VN
    Am J Physiol Lung Cell Mol Physiol; 2024 Jan; 326(1):L39-L51. PubMed ID: 37933452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic regulation of miR-17~92 contributes to the pathogenesis of pulmonary fibrosis.
    Dakhlallah D; Batte K; Wang Y; Cantemir-Stone CZ; Yan P; Nuovo G; Mikhail A; Hitchcock CL; Wright VP; Nana-Sinkam SP; Piper MG; Marsh CB
    Am J Respir Crit Care Med; 2013 Feb; 187(4):397-405. PubMed ID: 23306545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloid Fbxw7 Prevents Pulmonary Fibrosis by Suppressing TGF-β Production.
    He J; Du Y; Li G; Xiao P; Sun X; Song W; Lai L; Xia M; Zhang J; Wang Q
    Front Immunol; 2021; 12():760138. PubMed ID: 35069531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paired immunoglobulin-like receptor-B inhibits pulmonary fibrosis by suppressing profibrogenic properties of alveolar macrophages.
    Karo-Atar D; Moshkovits I; Eickelberg O; Königshoff M; Munitz A
    Am J Respir Cell Mol Biol; 2013 Apr; 48(4):456-64. PubMed ID: 23258232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.